News

Each year, with support from GOSH Charity and Sparks, we offer this prestigious award of £2,000 to one early independent researcher in paediatrics. We speak with this year's winner about her research to improve the lifelong health of preterm babies, and we hear her tips for aspiring researchers.

Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019 due to the presence of low levels of an impurity called NDMA. The European Medicines Agency has since confirmed its recommendation to suspend all ranitidine medicines in the EU.

As Camilla prepares to leave this role to become RCPCH President this spring, she looks back at some highlights - from a buzzing virtual conference to investment in paediatric recruitment - and encourages her fellow paediatricians to consider this important role.

Two new reports have been released outlining the findings of a snapshot survey of the UK's general paediatric and neonatal services and workforce in September 2019. The reports provide a pre-COVID benchmark and give recommendations to government, service planners and other decision makers about how ...

We look ahead to plans for digital growth charts, which will be available to parents and carers in 2021.

Russell updates members on how the College is responding to COVID-19. In this message, which has been emailed to all members, he outlines the College's actions towards COVID-19 and highlights advice and guidance for our members.

Russell has been speaking with quite a few members about COVID-19, also known as the novel coronavirus. In this message, which has been emailed to all members, he outlines what we know and how the situation is affecting the RCPCH.

The Government is to consider more flexible training for healthcare professionals who wish to switch discipline. The Department of Health and Social Care said that people who are already working as healthcare professionals "could train to become doctors and nurses more quickly now that the UK has le...

Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg because of a lack of evidence for benefit.